We are live on ! Find out more
BAMCO Inc

BAMCO Inc Portfolio holdings

AUM $33.1B
1-Year Est. Return 11.16%
This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+11.16%
3 Year Est. Return
+63.39%
5 Year Est. Return
+85.45%
10 Year Est. Return
+744.36%
AUM
$36.9B
AUM Growth
-$802M
Cap. Flow
-$438M
Cap. Flow %
-1.19%
Top 10 Hldgs %
43.05%
Holding
363
New
33
Increased
122
Reduced
122
Closed
36

Top Buys

Rank Stock Value
1
FDS icon
Factset
FDS
+$300M
2
MSCI icon
MSCI
MSCI
+$203M
3
CHH icon
Choice Hotels
CHH
+$193M
4
VTR icon
Ventas
VTR
+$79.1M
5
BIRK icon
Birkenstock
BIRK
+$68.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.89%
2 Financials 21.28%
3 Technology 18.11%
4 Healthcare 8.5%
5 Real Estate 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEM icon
276
Agnico Eagle Mines
AEM
$68.5B
$2.53M 0.01%
14,922
-6,544
-30% -$1.1M
HUBS icon
277
HubSpot
HUBS
$11.5B
$2.46M 0.01%
6,122
-3,180
-34% -$1.32M
VAC icon
278
Marriott Vacations Worldwide
VAC
$3.43B
$2.41M 0.01%
41,800
VRTX icon
279
Vertex Pharmaceuticals
VRTX
$123B
$2.36M 0.01%
5,200
PODD icon
280
Insulet
PODD
$11.4B
$2.24M 0.01%
7,886
+2,186
+38% +$683K
VGT icon
281
Vanguard Information Technology ETF
VGT
$139B
$2.02M 0.01%
+21,456
New +$2.04M
UNH icon
282
UnitedHealth
UNH
$387B
$1.98M 0.01%
6,000
+1,700
+40% +$576K
EHC icon
283
Encompass Health
EHC
$11.1B
$1.86M 0.01%
17,500
MU icon
284
Micron Technology
MU
$959B
$1.81M ﹤0.01%
+6,351
New +$1.46M
ELAN icon
285
Elanco Animal Health
ELAN
$12.9B
$1.81M ﹤0.01%
+80,000
New +$1.74M
HOOD icon
286
Robinhood
HOOD
$89.7B
$1.8M ﹤0.01%
15,950
-5,050
-24% -$657K
RHI icon
287
Robert Half
RHI
$4.28B
$1.56M ﹤0.01%
57,600
KYMR icon
288
Kymera Therapeutics
KYMR
$9.52B
$1.56M ﹤0.01%
20,000
+13,000
+186% +$878K
COF icon
289
Capital One
COF
$128B
$1.49M ﹤0.01%
6,135
+2,135
+53% +$475K
MDGL icon
290
Madrigal Pharmaceuticals
MDGL
$12.8B
$1.46M ﹤0.01%
2,500
-100
-4% -$51.1K
NVO
291
Novo Nordisk
NVO
$223B
$1.4M ﹤0.01%
27,426
+5,985
+28% +$306K
ALNY icon
292
Alnylam Pharmaceuticals
ALNY
$35.7B
$1.39M ﹤0.01%
3,500
DEI icon
293
Douglas Emmett
DEI
$2.1B
$1.37M ﹤0.01%
124,363
-1,625,078
-93% -$20.4M
XENE icon
294
Xenon Pharmaceuticals
XENE
$6.6B
$1.34M ﹤0.01%
30,000
ASND icon
295
Ascendis Pharma A/S
ASND
$17.1B
$1.19M ﹤0.01%
5,600
MS icon
296
Morgan Stanley
MS
$339B
$1.17M ﹤0.01%
+6,600
New +$1.1M
BLK icon
297
Blackrock
BLK
$166B
$1.13M ﹤0.01%
1,052
-48
-4% -$52.5K
VCTR icon
298
Victory Capital Holdings
VCTR
$6.16B
$1.05M ﹤0.01%
16,596
JKHY icon
299
Jack Henry & Associates
JKHY
$10.8B
$932K ﹤0.01%
5,110
-890
-15% -$148K
PGR icon
300
Progressive
PGR
$121B
$815K ﹤0.01%
3,580
-3,020
-46% -$682K

Similar funds

BAMCO Inc's Q4 2025 Portfolio in Review

As of Q4 2025, BAMCO Inc held 363 positions worth $36.9B, down 2.1% from $37.7B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

BAMCO Inc's Q4 2025 filing shows 33 new, 122 increased, 122 reduced and 36 closed positions. Its largest new stake was Champion Homes: 725,542 shares worth $61.3M. The largest sale was Gaming and Leisure Properties, an estimated $146M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 31% a quarter earlier, followed by Financials and Technology.

  • BAMCO Inc's largest Q4 2025 buy was Champion Homes: 725,542 shares worth $61.3M.
  • BAMCO Inc added most to Factset in Q4 2025, an estimated $300M increase.
  • BAMCO Inc's biggest Q4 2025 reduction was Gaming and Leisure Properties, cutting an estimated $146M.
  • BAMCO Inc fully exited Trex in Q4 2025, selling an estimated $82.1M.
  • BAMCO Inc's ten largest holdings make up 43% of its $36.9B portfolio in Q4 2025.
  • BAMCO Inc opened 33 new positions and closed 36 in Q4 2025.
  • BAMCO Inc's portfolio value fell 2.1% quarter-over-quarter to $36.9B.

Based on BAMCO Inc's 13F filing for Q4 2025, filed 17 Feb 2026.